Filing Details

Accession Number:
0000905148-23-001527
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-24 17:37:11
Reporting Period:
2023-11-21
Accepted Time:
2023-11-24 17:37:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1865494 Io Biotech Inc. IOBT Pharmaceutical Preparations (2834) 870909276
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1865633 Brian Burkavage C/O Io Biotech, Inc.
Ole Maaloes Vej 3
Copenhagen G7 2200
Chief Accounting Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-11-21 5,000 $0.99 6,500 No 4 P Direct
Common Stock Acquisiton 2023-11-22 5,000 $1.04 11,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The transaction was executed in multiple trades in prices ranging from $1.03 to $1.04, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.